CTI BioPharma Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Revenue	6,973	6,929	6,975	8,772	7,351	6,953	Upgrade
Revenue Growth (YoY)	5.27%	-0.66%	-20.49%	19.34%	5.71%	-3.98%	Upgrade
Cost of Revenue	3,369	3,369	3,588	4,864	3,926	3,697	Upgrade
Gross Profit	3,604	3,560	3,387	3,908	3,424	3,256	Upgrade
Selling, General & Admin	2,362	2,363	2,283	2,680	2,351	2,253	Upgrade
Other Operating Expenses	5.2	-	-	-	-	-	Upgrade
Operating Expenses	2,678	2,664	2,562	2,996	2,643	2,535	Upgrade
Operating Income	926.2	896.7	825.7	912	781.5	720.8	Upgrade
Interest Expense	-101.4	-89.7	-74.9	-73.9	-69.5	-72.6	Upgrade
Interest & Investment Income	47.3	34.8	21.8	6.6	0.3	0.2	Upgrade
Earnings From Equity Investments	-0.8	-0.9	-1.9	-0.4	3.9	1.6	Upgrade
Currency Exchange Gain (Loss)	-6.7	-6.7	11.6	0.9	8.6	2.2	Upgrade
Other Non Operating Income (Expenses)	-0.3	-	-	-	-	2.5	Upgrade
EBT Excluding Unusual Items	864.3	834.2	782.3	845.2	724.8	654.7	Upgrade
Merger & Restructuring Charges	-38.2	-48.1	-74.1	-83.1	-88.2	-17.5	Upgrade
Impairment of Goodwill	-	-	-	-3	-	-	Upgrade
Gain (Loss) on Sale of Assets	-10	-6.3	82.2	-56.8	196.8	-1.9	Upgrade
Asset Writedown	-1.4	-1.4	-	-3.3	-17.1	-	Upgrade
Pretax Income	814.7	778.4	790.4	699	816.3	635.3	Upgrade
Income Tax Expense	110.1	105	89.7	92.5	53.3	81.2	Upgrade
Earnings From Continuing Operations	704.6	673.4	700.7	606.5	763	554.1	Upgrade
Earnings From Discontinued Operations	41.1	61	27.4	-	-	-	Upgrade
Net Income to Company	745.7	734.4	728.1	606.5	763	554.1	Upgrade
Minority Interest in Earnings	0.3	-	0.2	-0.1	-	-	Upgrade
Net Income	746	734.4	728.3	606.4	763	554.1	Upgrade
Net Income to Common	746	734.4	728.3	606.4	763	554.1	Upgrade
Net Income Growth	7.35%	0.84%	20.10%	-20.52%	37.70%	-2.19%	Upgrade
Shares Outstanding (Basic)	169	173	177	177	177	177	Upgrade
Shares Outstanding (Diluted)	169	173	178	178	178	177	Upgrade
Shares Change (YoY)	-4.56%	-2.48%	-	0.11%	0.11%	0.11%	Upgrade
EPS (Basic)	4.42	4.25	4.11	3.42	4.31	3.13	Upgrade
EPS (Diluted)	4.41	4.24	4.10	3.41	4.30	3.13	Upgrade
EPS Growth	12.49%	3.44%	20.05%	-20.61%	37.57%	-2.31%	Upgrade
Free Cash Flow	739.3	704.8	771.8	513	390.1	444.3	Upgrade
Free Cash Flow Per Share	4.38	4.07	4.34	2.89	2.20	2.51	Upgrade
Dividend Per Share	1.310	1.271	1.154	1.048	0.952	0.865	Upgrade
Dividend Growth	11.82%	10.14%	10.12%	10.08%	10.06%	10.05%	Upgrade
Gross Margin	51.69%	51.38%	48.56%	44.55%	46.59%	46.83%	Upgrade
Operating Margin	13.28%	12.94%	11.84%	10.40%	10.63%	10.37%	Upgrade
Profit Margin	10.70%	10.60%	10.44%	6.91%	10.38%	7.97%	Upgrade
Free Cash Flow Margin	10.60%	10.17%	11.06%	5.85%	5.31%	6.39%	Upgrade
EBITDA	1,177	1,150	1,063	1,152	997.8	929.4	Upgrade
EBITDA Margin	16.88%	16.59%	15.24%	13.13%	13.57%	13.37%	Upgrade
D&A For EBITDA	251.1	252.8	237	239.8	216.3	208.6	Upgrade
EBIT	926.2	896.7	825.7	912	781.5	720.8	Upgrade
EBIT Margin	13.28%	12.94%	11.84%	10.40%	10.63%	10.37%	Upgrade
Effective Tax Rate	13.51%	13.49%	11.35%	13.23%	6.53%	12.78%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.